1-benzoyl-(3-cyclohexyl-3-methyl)thiourea

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-benzoyl-(3-cyclohexyl-3-methyl)thiourea
• 英文别名: N-[cyclohexyl(methyl)carbamothioyl]benzamide
• 化学式: C₁₅H₂₀N₂OS
• 分子量: 276.403
• InChiKey: RTJINZVXMASPJJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  19
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.47
• 拓扑面积：
  64.4
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1-benzoyl-(3-cyclohexyl-3-methyl)thiourea 在 一水合肼 作用下， 反应 3.0h， 生成 1-环己基-1-甲基硫脲
  参考文献：
  名称：

  囊性纤维化患者具有多种有益副作用的多靶点CFTR调节剂：简化治疗方法†。

  摘要：

  囊性纤维化（CF）是一种由囊性纤维化跨膜电导调节剂（CFTR）突变引起的多器官疾病。除了由于粘液积聚引起的呼吸障碍外，病毒和细菌还会引发急性肺部恶化，从而加速疾病的进展和死亡率。随着患者年龄的增长，治疗的复杂性也随之增加，简化治疗方案代表了CF的关键优先事项之一。最近，我们报道了通过靶向F508del-CFTR和PI4KIIIβ从而“充当CFTR校正剂和广谱肠病毒（EV）抑制剂”的多目标化合物的发现，该化合物能够“杀死一颗鸟而杀死两只鸟”。从这些初步的结果开始，我们在此报告了铅到铅的优化和多维结构-活性关系（SAR）研究，该研究导致了化合物23a。该化合物显示出良好的抗病毒和F508del-CFTR校正能力，与lumacaftor的加性/协同作用，以及有希望的体外吸收，分布，代谢和排泄（ADME）特性。它在体内具有良好的耐受性，在主要的生物分布器官中没有急性毒性和组织学改变的迹象。

  DOI：

  10.1021/acs.jmedchem.9b01416
• 作为产物：
  描述：

  苯甲酰氯 在 硫氰酸铵 作用下， 以 丙酮 为溶剂， 反应 4.0h， 生成 1-benzoyl-(3-cyclohexyl-3-methyl)thiourea
  参考文献：
  名称：

  Synthesis, structure and spectroscopic properties of cobalt(III) complexes with 1-benzoyl-(3,3-disubstituted)thiourea

  摘要：

  Reactions of Co(II) acetate with 1-benzoyl-(3-methyl-3-R)thiourea (R = ethyl, propyl, cyclohexyl and phenyl) and 1-benzoyl-(3-ethyl-3-benzyl)thiourea ligands, herein refer to as 1-benzoyl-(3,3-disubstituted)thiourea, derived from secondary alkyl- and arylamines gave [tris(1-benzoyl-(3, 3-disubstituted)thiourea)cobalt(III)] complexes. The neutral cobalt(III) complexes were afforded through a one-pot reaction between a deprotonated 1-benzoyl-(3,3-disubstituted)thiourea ligands with cobalt(II) acetate with a 1:3 ratio in methanol. These complexes were characterized on the basis of elemental analysis, mass spectrometry, magnetic susceptibility measurement, X-ray crystallography and spectroscopic techniques namely infrared, UV-Vis and nuclear magnetic resonance. Based on the magnetic susceptibility and spectroscopic data as well as X-ray crystallographic structure of the octahedron [tris(1-benzoyl-(3-methyl-3-phenyl)thiourea)cobalt(III)] complex, it can be concluded that the ligands behave as bidentate O,S chelate. (C) 2013 Published by Elsevier Ltd.

  DOI：

  10.1016/j.poly.2013.11.005

文献信息

• Multitarget CFTR Modulators Endowed with Multiple Beneficial Side Effects for Cystic Fibrosis Patients: Toward a Simplified Therapeutic Approach
  作者：Sabrina Tassini、Emily Langron、Leen Delang、Carmen Mirabelli、Kristina Lanko、Emmanuele Crespan、Miroslava Kissova、Giulia Tagliavini、Greta Fontò、Simona Bertoni、Simone Palese、Carmine Giorgio、Francesca Ravanetti、Luisa Ragionieri、Claudio Zamperini、Arianna Mancini、Elena Dreassi、Giovanni Maga、Paola Vergani、Johan Neyts、Marco Radi

  DOI：10.1021/acs.jmedchem.9b01416

  日期：2019.12.12

  enterovirus (EV) inhibitors. Starting from these preliminary results, we report herein a hit-to-lead optimization and multidimensional structure–activity relationship (SAR) study that led to compound 23a. This compound showed good antiviral and F508del-CFTR correction potency, additivity/synergy with lumacaftor, and a promising in vitro absorption, distribution, metabolism, and excretion (ADME) profile

  囊性纤维化（CF）是一种由囊性纤维化跨膜电导调节剂（CFTR）突变引起的多器官疾病。除了由于粘液积聚引起的呼吸障碍外，病毒和细菌还会引发急性肺部恶化，从而加速疾病的进展和死亡率。随着患者年龄的增长，治疗的复杂性也随之增加，简化治疗方案代表了CF的关键优先事项之一。最近，我们报道了通过靶向F508del-CFTR和PI4KIIIβ从而“充当CFTR校正剂和广谱肠病毒（EV）抑制剂”的多目标化合物的发现，该化合物能够“杀死一颗鸟而杀死两只鸟”。从这些初步的结果开始，我们在此报告了铅到铅的优化和多维结构-活性关系（SAR）研究，该研究导致了化合物23a。该化合物显示出良好的抗病毒和F508del-CFTR校正能力，与lumacaftor的加性/协同作用，以及有希望的体外吸收，分布，代谢和排泄（ADME）特性。它在体内具有良好的耐受性，在主要的生物分布器官中没有急性毒性和组织学改变的迹象。
• Synthesis, structure and spectroscopic properties of cobalt(III) complexes with 1-benzoyl-(3,3-disubstituted)thiourea
  作者：Siew San Tan、Aisha A. Al-abbasi、Mohamed Ibrahim Mohamed Tahir、Mohammad B. Kassim

  DOI：10.1016/j.poly.2013.11.005

  日期：2014.1

  Reactions of Co(II) acetate with 1-benzoyl-(3-methyl-3-R)thiourea (R = ethyl, propyl, cyclohexyl and phenyl) and 1-benzoyl-(3-ethyl-3-benzyl)thiourea ligands, herein refer to as 1-benzoyl-(3,3-disubstituted)thiourea, derived from secondary alkyl- and arylamines gave [tris(1-benzoyl-(3, 3-disubstituted)thiourea)cobalt(III)] complexes. The neutral cobalt(III) complexes were afforded through a one-pot reaction between a deprotonated 1-benzoyl-(3,3-disubstituted)thiourea ligands with cobalt(II) acetate with a 1:3 ratio in methanol. These complexes were characterized on the basis of elemental analysis, mass spectrometry, magnetic susceptibility measurement, X-ray crystallography and spectroscopic techniques namely infrared, UV-Vis and nuclear magnetic resonance. Based on the magnetic susceptibility and spectroscopic data as well as X-ray crystallographic structure of the octahedron [tris(1-benzoyl-(3-methyl-3-phenyl)thiourea)cobalt(III)] complex, it can be concluded that the ligands behave as bidentate O,S chelate. (C) 2013 Published by Elsevier Ltd.